EP Patent

EP3972954A1 — Siponimod maleic acid and fumaric acid salt

Assigned to Synthon BV · Expires 2022-03-30 · 4y expired

What this patent protects

The presented invention relates to salts of Siponimod with Fumaric acid (1:1) and solid Forms 1 and 2 thereof. The presented invention further relates to salts of Siponimod with Maleic acid (1:1) and solid Forms 1, 2, 3, 4, 5, 6, 7, 8 and 9 thereof.

USPTO Abstract

The presented invention relates to salts of Siponimod with Fumaric acid (1:1) and solid Forms 1 and 2 thereof. The presented invention further relates to salts of Siponimod with Maleic acid (1:1) and solid Forms 1, 2, 3, 4, 5, 6, 7, 8 and 9 thereof.

Drugs covered by this patent

Patent Metadata

Patent number
EP3972954A1
Jurisdiction
EP
Classification
—
Expires
2022-03-30
Drug substance claim
No
Drug product claim
No
Assignee
Synthon BV
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.